APA (7th ed.) Citation

Zheng, H., Xian, H., Zhang, W., Lu, C., Pan, R., Liu, H., & Xu, Z. (2025). BCMA-targeted therapies for multiple myeloma: Latest updates from 2024 ASH annual meeting. Journal of Hematology & Oncology, 18(1), 1. https://doi.org/10.1186/s13045-025-01675-5

Chicago Style (17th ed.) Citation

Zheng, Huijian, Huajian Xian, Wenjie Zhang, Chaoqun Lu, Renyao Pan, Han Liu, and Zhenshu Xu. "BCMA-targeted Therapies for Multiple Myeloma: Latest Updates from 2024 ASH Annual Meeting." Journal of Hematology & Oncology 18, no. 1 (2025): 1. https://doi.org/10.1186/s13045-025-01675-5.

MLA (9th ed.) Citation

Zheng, Huijian, et al. "BCMA-targeted Therapies for Multiple Myeloma: Latest Updates from 2024 ASH Annual Meeting." Journal of Hematology & Oncology, vol. 18, no. 1, 2025, p. 1, https://doi.org/10.1186/s13045-025-01675-5.